Report: Breaking the Cost Barrier on Biomanufacturing
A new report from AAB member Synonym (and The Boston Consulting Group) lays out the roadmap to biomanufacturing ‘moment' and predicts the market for specialty bioproducts to explode to $200 billion the next decade. Download your free copy here.




Comments